Key points for validating CE methods, particularly in pharmaceutical analysis

LCGC North America

Volumn 19, Issue 5, 2001, Pages 498-505

  Fabre, H ^a   Altria, K D ^b  

^a UNIV MONTPELLIER   (France)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 19944396546     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. U.S. Pharmacopeia 24-National Formulary 19 (U.S. Pharmacopeia Convention, Rockville, Maryland, 2nd supplement, 2000), pp. 2896-2900.
2. European Pharmacopoeia (European Directorate for the Quality of Medicines, Strasbourg, France, 3rd ed., 2001 addendum, 2001), pp. 35-40.
3. European Pharmacopoeia (European Directorate for the Quality of Medicines, Strasbourg, France, 3rd ed., 2001 addendum, 2001), pp. 1061-1063.
4. Japanese Pharmacopeial Forum (Ministry of Health and Welfare, Tokyo, Japan, 1999), pp. 178-201.
5. Pharmeuropa 11(2), 411-412 (1999).
6. The Fitness for Purpose of Analytical Methods (Eurachem, LGC, Teddington, United Kingdom, 1998).
7. "Text on Validation of Analytical Procedures: Methodology" (International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, 1996).
8. G. Castaneda Penalvo and H. Fabre, Chromatographia 42, 159-164 (1996).
9. K.P. Stubberud and O. Astrom, J. Chromatogr. A 826, 95-102 (1998).
10. M.A. Kelly, K.D. Altria, C. Grace, and B.J. Clark, J. Chromatogr. A 798, 297-306 (1998).
11. J. Chen, Fausnaugh-Pollitt and L. Gu, J. Chromatogr. A 853, 197-206 (1999).
12. K.D. Altria, S.M. Bryant, and T. Hadgett, J. Pharm. Biomed. Anal. 15, 1091-1101 (1997).
13. B.R. Thomas, X.G. Fang, X. Chen, R.J. Tyrell, and S. Ghodbane, J. Chromatogr. A 657, 383-394 (1994).
14. K.D. Altria, P. Frake, I. Gill, T. Hadgett, M.A. Kelly, and D.R. Rudd, J. Pharm. Biomed. Anal. 13, 951-957 (1995).
15. M.D. Blanchin, B. Baalbaki, N. Bosc, and H. Fabre, Anal. Chim. Acta 415, 67-73 (2000).
16. H. Fabre and N. Mesplet, J. Chromatogr. A 897, 329-338 (2000).
17. C.E. Sanger-van de Griend, H. Wahlstrom, K. Groningsson, and M. Widahl-Nasman, J. Pharm. Biomed. Anal. 15, 1051-1061 (1997).
18. J.E. Noroski, D.J. Mayo, and M. Moran, J. Pharm. Biomed. Anal. 13, 52-54 (1995).
19. H. Fabre, M.D. Blanchin, E. Julien, C. Segonds, B. Mandrou, and N. Bosc, J. Chromatogr. A 772, 265-269 (1997).
20. L. Zhou and A. Dovletoglou, J. Chromatogr. A 763, 279-284 (1997).
21. K.D. Altria, E. Creasey, and J.S. Howells, J. Liq. Chromatogr. 21, 1093-1105 (1998).
22. J. Bullock, J. Pharm. Biomed. Anal. 14, 845-854 (1996).
23. K.D Altria and Y.K. Dave, J. Chromatogr. A 633, 221-225 (1993).
24. M.A. Kelly, K.D. Altria, and B.J. Clark, J. Chromatogr. A 768, 73-80 (1997).
25. K.D. Altria and F. Campi, LCGC 17(3), 236-243 (1999).
26. N. Bennani and H. Fabre, Anal. Chim. Acta, in press, 2001.
27. H. Fabre, M.D. Blanchin, and N. Bosc, Anal. Chim. Acta 381, 29-37 (1999).
28. H. Fabre, C. Perrin, and N. Bosc, J. Chromatogr. A 853, 421-430 (1999).
29. K.D. Altria. and H. Fabre, Chromatographia 40, 313-320 (1995)
30. J.C. Hudson, M. Golin, M. Malcolm, and C.F. Whiting, Can. Soc. Forens. Sci. 31, 1-29 (1998)
31. T. Wielgos, P. Turner, and K. Havel, J. Cap. Electroph. 4, 273-278 (1997).
32. K.D. Altria and D. Hindocha, LCGC 16(9), 835-841 (1998).
33. K.D. Altria, R.C. Harden, M. Hart, J. Hevizi, P.A. Hailey, J.V. Makwana, and M.J. Porsmouth, J. Chromatogr. A 641, 147-153 (1993)
34. K.D. Altria, N.G. Clayton, M. Hart, R.C. Harden, J. Hevizi, J.V. Makwana, and M.J. Porsmouth, Chromatographia 39, 180-184 (1994).
35. K.D. Altria, N.G. Clayton, R.C. Harden, J.V. Makwana, and M.J. Porsmouth, Chromatographsa 40, 47-50 (1995).
36. K.D. Altria and S.M. Bryant, "Quantitative Analysis of Small Ions by Capillary Electrophoresis," Beckman Coulter Inc. (Sunnyvale, California, 1997), pp. 1-40.
37. K.D. Altria, LCGC 11(6), 438-442 (1993).